Neil Stahl, EVP Research and Development at REGENERON PHARMACEUTICALS INC (REGN), sold 38,143 shares at $295.09 ($11.2M) on 2018-05-24, disclosed to the SEC on 2018-05-25.
Open-market sale of $11.2M REGN by EVP Research and Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $293.68 | 15,329 | $4.5M | 40.1% |
| 2 | $295.09 | 11,407 | $3.4M | 30.0% |
| 3 | $295.09 | 11,407 | $3.4M | 30.0% |
| Total | $294.52 avg | 38,143 | $11.2M | 100% |
| Filing → |
| REGN | SELL | 2023-08-23 | $19.6M | — | Filing → |
| REGN | SELL | 2022-08-08 | $28.4M | — | Filing → |
| REGN | SELL | 2021-05-18 | $18.2M | — | Filing → |